Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
385
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
-1.73M
-
Total reported value, excl. options
-
$7.65B
-
Value change
-
-$62.7M
-
Put/Call ratio
-
1.22
-
Number of buys
-
197
-
Number of sells
-
-171
-
Price
-
$62.48
Significant Holders of Guardant Health, Inc. - Common Stock (GH) as of Q3 2025
456 filings reported holding GH - Guardant Health, Inc. - Common Stock as of Q3 2025.
Guardant Health, Inc. - Common Stock (GH) has 385 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 124M outstanding shares and own 98.9% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (11.9M shares), BlackRock, Inc. (11.4M shares), BAILLIE GIFFORD & CO (5.13M shares), Invesco Ltd. (4.93M shares), Capital International Investors (4.69M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.22M shares), Deep Track Capital, LP (4.15M shares), EVENTIDE ASSET MANAGEMENT, LLC (3.32M shares), WELLINGTON MANAGEMENT GROUP LLP (3.25M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.94M shares).
This table shows the top 385 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.